Laboratory Animals: Animal Welfare Act

Roger Gale Excerpts

Monday 7th February 2022 Westminster Hall

[Sir Roger Gale (North Thanet) (Con)]

I had not intended to speak in this debate; I came to listen. In the light of some of the comments, however, I basically want to ask a question and to put down a caveat.

In the early 1980s, the splendid Bill Annett, who was the driving force behind the Fund for the Replacement of Animals in Medical Experiments, prevailed on me to become the founding chairman of the all-party parliamentary group for FRAME. It was supported by Professor Michael Balls, an eminent professor at Nottingham University, whose work in the validation of alternatives is probably second to none. Michael went on to become the director of the European Centre for the Validation of Alternative Methods.

The Animals (Scientific Procedures) Act 1986 was taken through the House by, from memory, my right hon. Friend David Mellor, who paid a considerable personal price for his work on that piece of legislation. The Act, when it hit the statute book, was regarded as a benchmark for animals legislation. Well, rather a few years have gone by since then, Mr Pritchard. We thought we were on a roll, but it saddens me to say that far too little progress to validate alternative methods has been made since.

We all want to see zero use of animals in medicine, but for the foreseeable future it is clear that that is not going to happen, for a variety of reasons, including, as my hon. Friend the Member for Runnymede and Weybridge (Dr Spencer) said, because animals are used in experimentation during the creation of medicines for animals. Clearly, that is necessary for the foreseeable future.

I stand to be corrected, but I believe it is also still the case that the licensing of new medical products around the world depends upon the use of animals. Whether that is necessary or not is immaterial, in this context, as it is a fact. If someone wants a licence for a new pharmaceutical entity for use in Japan, the United States or Europe, it is a requirement that it has been tested on animals. Personally, I happen to believe that the science has by far overtaken that necessity. The hon. Member for York Central (Rachael Maskell) referred to work with genomics. It is infinitely more possible now to do in vitro rather than in vivo testing of pharmaceutical products, and we should be moving faster in that direction.

My caveat to those who say, “Ban it now,” is that if we do that, those tests will still have to take place internationally and we would be in danger—I do not think this is a spurious argument—of simply transferring the problem from A to B, and patting ourselves on the back, while finding that the animals are still being used in testing in other countries, under far worse conditions than they are treated in the United Kingdom. Whether we like it or not, the veterinary profession takes a clear view of the work of the named vets in pharmaceutical companies, and I have no reason to suppose that they are anything other than humane and responsible.

My question for the Minister is, how can we use the Animal Welfare (Sentience) Bill, or other animal welfare legislation going through the House, to bring the process up to date, to advance progress towards the abolition of the use of animals in medical experiments and to do that in such a way that we can carry the international community with us? While a ban in the United Kingdom might make us feel good, it is not going to solve the problem. There has to be a global and, most certainly, a European solution, as well as a national one.